FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 080105003 | 72934-1313 | 72934-1313-2 | Clindamycin Phosphate; Niacinamide; Spironolactone; Tretinoin | 1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL | 2024-2 | valid | 2026-10-15 | |
| SKNV | 72934-1313 | 72934-1313-2 | Deoxiademtar Gel | 011216 CLINDAMYCIN 1% / NIACINAMIDE 4% / SPIRONOLACTONE 2% / TRETINOIN 0.025% Gel | 1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-1313 | 72934-1313-2 | Clindamycin Phosphate; Niacinamide; Spironolactone; Tretinoin | 1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL | 2024-1 | valid | 2026-10-15 | |
| SKNV | 080105003 | 72934-1313 | 72934-1313-2 | Clindamycin Phosphate; Niacinamide; Spironolactone; Tretinoin | 1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL | 2023-2 | valid | 2026-10-15 |